American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,494 | 55,200 | 71,511 | 100,905 | 90,988 |
| Receivables | 105,401 | 99,526 | 112,642 | 130,211 | 79,605 |
| Inventories | 7,752 | 11,433 | 4,665 | 4,676 | 4,291 |
| Other current assets | 50,099 | 577 | 0 | 0 | 0 |
| TOTAL | $220,014 | $194,863 | $213,816 | $254,290 | $193,747 |
| Non-Current Assets | |||||
| PPE Net | 151,175 | 180,268 | 168,537 | 170,118 | 142,701 |
| Intangibles | 563,095 | 595,967 | 598,513 | 598,718 | 594,980 |
| Other Non-Current Assets | 152,507 | 14,745 | 9,285 | 17,102 | 6,850 |
| TOTAL | $866,777 | $790,980 | $776,335 | $785,938 | $744,531 |
| Total Assets | $1,086,791 | $985,843 | $990,151 | $1,040,228 | $938,278 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 38,779 | 42,855 | 44,534 | 48,274 | 25,610 |
| Accounts payable and accrued liabilities | 49,539 | 59,082 | 33,421 | 31,127 | 22,571 |
| Accrued Expenses | 74,789 | 95,703 | 93,560 | 92,125 | 49,292 |
| TOTAL | $190,935 | $197,640 | $171,515 | $171,526 | $97,473 |
| Non-Current Liabilities | |||||
| Long Term Debt | 548,835 | 517,511 | 515,554 | 522,058 | 657,372 |
| Other Non-Current Liabilities | 219,841 | 106,378 | 90,085 | 84,399 | 43,462 |
| TOTAL | $811,317 | $678,292 | $668,794 | $704,977 | $790,095 |
| Total Liabilities | $1,002,252 | $875,932 | $840,309 | $876,503 | $887,568 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,997 | 32,564 | 32,050 | 30,895 | N/A |
| Common Shares | 197 | 196 | 193 | 184 | 98 |
| Retained earnings | -178,241 | -164,451 | -135,898 | -131,301 | -128,261 |
| Other shareholders' equity | 161,839 | 168,451 | 186,449 | 194,155 | 178,873 |
| TOTAL | $84,539 | $109,911 | $149,842 | $163,725 | $50,710 |
| Total Liabilities And Equity | $1,086,791 | $985,843 | $990,151 | $1,040,228 | $938,278 |